J. Schaffer et al., Recombinant versus natural human In-111-beta(2)-microglobulin for scintigraphic detection of A beta(2)m amyloid in dialysis patients, KIDNEY INT, 58(2), 2000, pp. 873-880
Background We previously introduced scintigraphy with I-131-labeled beta(2)
-microglobulin (beta(2)m), purified from uremic hemofiltrate, that is, "nat
ural" beta(2)m, to specifically detect beta(2)m-associated amyloidosis (A b
eta(2)m) in hemodialysis (HD) patients.
Methods. To improve the safety and resolution of the scan, we covalently bo
und the chelator diethylenetriaminepentaacetic acid to natural beta(2)m to
allow radiolabeling with In-111. In a second step, we generated and evaluat
ed the usage of recombinant human beta(2)m (rh beta(2)m) for scintigraphy.
Results. Using natural In-111-labeled beta(2)m, eight patients on HD for 0
to 17 years, without evidence of A beta(2)m, were scanned. Whole-body scint
igraphy at 48 to 72 hours postinjection revealed no significant tracer accu
mulation over joint regions. In contrast, nine patients on HD for 10 to 21
years with clinical, radiological, or histologic (N = 4) evidence of A beta
(2)m showed selective tracer uptake over various joint regions. Tracer accu
mulation in visceral organs, which could not be related to tracer eliminati
on or metabolism, was not detected. Compared with the previous I-131 beta(2
)m scan, scintigraphy with In-111-labeled beta(2)m offered highly improved
image contrast, increased sensitivity, and a 50 to 70% reduction of the rad
iation exposure. Scanning with In-111-labeled recombinant human beta(2)m wa
s performed in six patients: No significant tracer accumulation was observe
d over joint regions in two patients on short-term HD without evidence of A
beta(2)m; in contrast, local tracer accumulations similar to those observe
d with natural beta(2)m could be demonstrated in four long-term (10 to 27 y
ears) HD patients with clinical, radiological, and histologic (N = 1) evide
nce of A beta(2)m.
Conclusion. Scintigraphy for A beta(2)m with In-111-labeled rh beta(2)m pro
vides a homogenous and safe recombinant protein source and leads to enhance
d sensitivity and lower radiation exposure.